0001950047-24-000716.txt : 20240207
0001950047-24-000716.hdr.sgml : 20240207
20240207161841
ACCESSION NUMBER: 0001950047-24-000716
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 24604591
BUSINESS ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-262-7002
MAIL ADDRESS:
STREET 1: 1715 38TH ST
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOORE JOHN R
CENTRAL INDEX KEY: 0001191702
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 3200 WALNUT ST
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001191702
XXXXXXXX
LIVE
0001710072
EDGEWISE THERAPEUTICS INC
001-40236
1715 38th Street
Boulder
CO
80301
720-262-7002
JOHN R MOORE
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
38th Fl.
New York
NY
10004
29835
585661.05
63461608
02/07/2024
NASDAQ
Common
02/07/2024
Exercise of Stock Options
Issuer
N
29835
02/07/2024
Cash
N
10b5-1 Sales for JOHN R MOORE
1715 38th Street
Boulder
CO
80301
Common
12/27/2023
8497
89218.50
The securities to be sold were and will be received upon the exercise of stock options over the next three months.
02/07/2024
06/30/2023
/s/ John R Moore